According to the Low Dose Naltrexone home page [LDN], LDN has been seen
to benefit HIV and AIDS, both with and without concurrent HAART.
However, LDN has not been found to benefit HIV-encephalopathy.
[Bihari1988]
[Bihari2003]
[Bihari2013 🕮 ]
[Traore2011],
[Traore2011a],
[LDN].
Dr. Deanna Windham states that "LDN improves the immune systems's response to infections, including"
HIV, "likely due to its immunomodulatory effects on T cells, monocytes, and macrophages"
[Elsegood2016, pg 36]
Dr. Weyrich has been trained to use Low Dose Naltrexone (LDN), but lacks the
specialized training necessary to treat patients with HIV or AIDS.
Please see What is Low Dose Naltrexone?
for more information.